NCT07193381

Brief Summary

This prospective observational cohort study aims to evaluate the relationship between ductus venosus Doppler parameters and perinatal outcomes in pregnancies complicated by intrauterine growth restriction (IUGR). Pregnant women diagnosed with IUGR will undergo longitudinal Doppler assessments of the ductus venosus during the third trimester. The Doppler indices will be correlated with perinatal outcomes, including Apgar scores, neonatal intensive care unit (NICU) admission, and perinatal mortality. The study seeks to determine whether serial ductus venosus Doppler measurements can serve as predictive markers of adverse neonatal outcomes in IUGR pregnancies.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
81

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2025

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

September 13, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

September 25, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2026

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
Last Updated

March 17, 2026

Status Verified

March 1, 2026

Enrollment Period

5 months

First QC Date

September 13, 2025

Last Update Submit

March 14, 2026

Conditions

Keywords

Ductus VenosusDoppler UltrasoundNeonatal Intensive Care Unit (NICU)

Outcome Measures

Primary Outcomes (1)

  • Composite adverse perinatal outcome (perinatal mortality, Apgar score <7 at 5 minutes, NICU admission)

    A composite outcome including perinatal mortality, Apgar score \<7 at 5 minutes, and NICU admission. The association between ductus venosus Doppler indices and this composite outcome will be analyzed.

    From delivery until neonatal discharge (up to 28 days postpartum)

Secondary Outcomes (1)

  • Longitudinal change (slope) of ductus venosus PI during third trimester

    From study enrollment through delivery (up to 14 weeks), assessed weekly

Study Arms (1)

IUGR Pregnancies

Pregnant women diagnosed with intrauterine growth restriction will be followed longitudinally with serial ductus venosus Doppler assessments during the third trimester. Perinatal outcomes will be recorded until delivery and the early neonatal period.

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Pregnant women aged 18-45 years with singleton pregnancies diagnosed with intrauterine growth restriction (IUGR) will be recruited from the Department of Perinatology at Izmir City Hospital. Eligible participants will be followed with serial Doppler ultrasound examinations of the ductus venosus during the third trimester and monitored until delivery and the early neonatal period.

You may qualify if:

  • Female participants aged 18-45 years
  • Singleton pregnancy
  • Intrauterine growth restriction (IUGR) with estimated fetal weight \<10th percentile for gestational age
  • Gestational age ≥24 weeks at enrollment
  • Ability to comply with scheduled follow-up visits and Doppler examinations
  • Signed informed consent obtained

You may not qualify if:

  • Multiple gestations (twins or higher-order pregnancies)
  • Major fetal congenital anomalies
  • Known chromosomal abnormalities
  • Maternal chronic systemic diseases likely to affect fetal growth (e.g., uncontrolled diabetes mellitus, severe renal disease, severe hypertension)
  • Maternal infections known to impact fetal growth (e.g., TORCH infections)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Izmir City Hospital

Izmir, Bayrakli, 35540, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Fetal Growth Retardation

Condition Hierarchy (Ancestors)

Fetal DiseasesPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesGrowth DisordersPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Hakan Golbasi, Assistant Professor

    Izmir City Hospital

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Months
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR INVESTIGATOR
PI Title
MD, Perinatology Specialist

Study Record Dates

First Submitted

September 13, 2025

First Posted

September 25, 2025

Study Start

September 1, 2025

Primary Completion

February 1, 2026

Study Completion

March 1, 2026

Last Updated

March 17, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared because the dataset is limited to a single-center observational study and will only be used for publication of aggregated results.

Locations